Abstract
Background Eating disorder (ED) symptoms are prevalent in the general population, but their shared genetic underpinnings with psychiatric, metabolic, and anthropometric traits are not known. Here, we examined if polygenic scores (PGS) of traits associated with anorexia nervosa are also associated with adolescent ED symptoms in the Avon Longitudinal Study of Parents and Children (ALSPAC).
Methods We calculated PGS for 25 traits (16 psychiatric, 4 metabolic, and 5 anthropometric) and investigated their associations with eight ED symptoms, including behaviors such as fasting for weight loss and cognitions such as body dissatisfaction (n range=2,991-6,013).
Results Higher attention deficit hyperactivity disorder PGS and lower educational attainment PGS were associated with fasting for weight loss. Higher insomnia PGS was associated with increased body dissatisfaction. We found no evidence of an association between metabolic trait PGS and any ED symptom. Regarding anthropometrics, fat-free mass, fat mass, and body fat percentage PGSs, were positively associated with binge eating, excessive exercise, fasting for weight loss, body dissatisfaction, and weight and shape concern.
Conclusions ED symptoms are genetically associated with psychiatric and anthropometric, but not with metabolic traits. Our findings provide insights for future genetic research investigating why some individuals with ED symptoms progress to develop threshold EDs while others do not.
Competing Interest Statement
GB has received grant funding from and served as a consultant to Eli Lilly, has received honoraria from Illumina and has served on advisory boards for Otsuka. CB is a grant recipient from and has served on advisory boards for Shire/Takeda and has been a consultant for Idorsia. She receives royalties from Pearson.
Funding Statement
This work was supported by the UK Medical Research Council and the Medical Research Foundation (ref: MR/R004803/1). The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2 and 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf); This research was specifically funded by the NIHR (CS/01/2008/014), the NIH (MH087786-01). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. NM and CB acknowledge funding from the National Institute of Mental Health (R21 MH115397). CMB is supported by NIMH (R01MH120170; R01MH119084; R01MH118278; U01 MH109528); Brain and Behavior Research Foundation Distinguished Investigator Grant; Swedish Research Council (Vetenskapsradet, award: 538-2013-8864); CH and CMB are funded by the Lundbeck Foundation (Grant no. R276-2018-4581). MH is funded by a fellowship from the Medical Research Council UK (MR/T027843/1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and the authors will serve as guarantors for the contents of this paper. The funders were not involved in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (Bristol and Weston Health Authority: E1808 Children of the Nineties: ALSPAC, 28th November 1989 (for details see: www.bristol.ac.uk/alspac/researchers/research-ethics/). Consent for biological samples was obtained in accordance with the Human Tissue Act (2004). Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. The main caregiver initially provided consent for child participation and from the age 16 years the offspring themselves have provided informed written consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Please note that the study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool" and reference the following webpage: http://www.bristol.ac.uk/alspac/researchers/our-data/.
